Starsource Multitrade Limited, formerly Chemo Pharma Laboratories Limited, is an India-based company. The Company was engaged in manufacturing operations. It has no operations and does not generate any revenue. The Company is exploring new business opportunities.

Employees

Sector

Investment Holding Companies

More about the company

Quotes

Date	Price	Change	Volume
25/06/26	₹90.90	-1.36%	2,417
24/06/26	₹92.15	-4.26%	382
23/06/26	₹96.25	+1.69%	362
22/06/26	₹94.65	-4.68%	20,585
19/06/26	₹99.30	-4.98%	1,733

Delayed Quote Bombay S.E.

More quotes

Income Statement and Estimates

More financial data

Delayed Bombay S.E. Other stock markets 18:10:35 25/06/2026 HKT			5-day change	1st Jan Change
90.90 ^INR	-1.36%		-13.01%	-20.75%

05-29	Starsource Multitrade Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
02-12	Starsource Multitrade Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI

Market Cap	167M 1.77M 1.55M 1.43M 1.34M 2.51M 2.56M 17.17M 6.65M 82.25M 6.64M 6.49M 286M	P/E 2024	8.12x	P/E 2025	54.6x
Enterprise Value	60.62M 642K 564K 520K 486K 912K 928K 6.24M 2.42M 29.88M 2.41M 2.36M 104M	EV / Sales 2024	1.98x	EV / Sales 2025	13x
Free-Float	60.16%	Yield 2024 *	-	Yield 2025	-

05-29	Starsource Multitrade Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
02-12	Starsource Multitrade Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11-14	Starsource Multitrade Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
01/10/25	Chemo Pharma Laboratories Limited has Changed its Name to Starsource Multitrade Limited	CI
25/09/25	Chemo Pharma Laboratories Limited Announces Changes to Its Board	CI
25/09/25	Chemo Pharma Laboratories Limited Appoints and Regularize Utsav Trivedi as CFO	CI
25/09/25	Chemo Pharma Laboratories Limited Appoints and Regularize Ruchit Mehta as Chief Executive Officer	CI
12/09/25	Chemo Pharma Laboratories Limited Announces Company Secretary and Compliance Officer, Effective from September 12, 2025	CI
12/08/25	Chemo Pharma Laboratories Limited Decides to Shift the Registered Office	CI
12/08/25	Chemo Pharma Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
29/05/25	Starsource Multitrade Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025	CI
27/05/25	Chemo Pharma Laboratories to Open New Corporate Office in Ahmedabad, India; Shares Down 4%	MT
23/04/25	Chemo Pharma Laboratories Limited Approves the Appointment of Bhawna Rajput as Company Secretary and Compliance Officer, Effective 16 April, 2025	CI

1 day	-1.36%
1 week	-13.01%
Current month	-20.92%
1 month	-20.61%
3 months	-9.94%
6 months	-14.69%
Current year	-20.75%

Starsource Multitrade Limited Stock

Stocks

CHEMOPH6

INE320M01019

Investment Holding Companies

Valuation: Starsource Multitrade Limited

Chart: Starsource Multitrade Limited

Latest news : Starsource Multitrade Limited

Quotes and Performance

Course Extremes

Managers and Directors: Starsource Multitrade Limited

Shell Companies

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	87.55	104.25
1 month	87.55	125
Current year	75	152.9
1 year	75	152.9
3 years	27.17	154
5 years	21.7	154
10 years	5.45	154

Manager	Title	Age	Since
Ruchit Mehta CEO	Chief Executive Officer	35	16/04/2025
Utsav Trivedi DFI	Director of Finance/CFO	27	16/04/2025
Aditya Agarwal CMP	Compliance Officer	-	12/09/2025

Director	Title	Age	Since
Simran Ankleshwar Tripathi BRD	Director/Board Member	-	31/12/2024
Ruchit Mehta BRD	Director/Board Member	35	16/04/2025
Simran Utsav Trivedi BRD	Director/Board Member	30	31/12/2024

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STARSOURCE MULTITRADE LIMITED	-1.36%	-13.01%	-22.67%	+152.50%	1.44M
EINRIDE AB	-6.61%	-22.79%	-	-	910M
TEAMSHARES INC.	+0.47%	-5.48%	+0.94%	-	967M
CENTIEL AG	-6.26%	-2.68%	+396.28%	-59.80%	853M
CHURCHILL CAPITAL CORP XI	+3.75%	+20.72%	-	-	693M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	-0.30%	-0.30%	-	-	641M
BAIN CAPITAL GSS INVESTMENT CORP.	0.00%	+0.69%	-	-	600M
CANTOR EQUITY PARTNERS IV, INC.	+0.10%	-0.10%	-	-	593M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	+0.61%	+3.23%	-	-	569M
Average	-1.07%	-0.95%	+124.85%	+46.35%	647.55M
Weighted average by Cap.	-1.39%	-0.43%	+186.05%	-59.44%

	2024	2025
Net sales	18.38M 195K 171K 158K 147K 276K 282K 1.89M 733K 9.06M 732K 716K 31.49M	6.2M 65.69K 57.7K 53.16K 49.71K 93.23K 94.94K 638K 247K 3.06M 247K 241K 10.62M
Net income	12M 127K 112K 103K 96.27K 181K 184K 1.24M 478K 5.92M 478K 467K 20.56M	3.42M 36.27K 31.86K 29.35K 27.44K 51.47K 52.41K 352K 136K 1.69M 136K 133K 5.86M
Net Debt	-61.06M -647K -568K -524K -490K -918K -935K -6.28M -2.43M -30.1M -2.43M -2.38M -105M	-106M -1.13M -989K -911K -852K -1.6M -1.63M -10.93M -4.23M -52.36M -4.23M -4.13M -182M